tradingkey.logo
tradingkey.logo
Suchen

Biote Corp

BTMD
Zur Watchlist hinzufügen
2.062USD
+0.072+3.61%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
61.83MMarktkapitalisierung
4.10KGV TTM

mehr Informationen über Biote Corp Unternehmen

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Biote Corp Informationen

BörsenkürzelBTMD
Name des UnternehmensBiote Corp
IPO-datumMar 02, 2021
CEOChristensen (Bret)
Anzahl der mitarbeiter217
WertpapierartOrdinary Share
GeschäftsjahresendeMar 02
Addresse1875 W. Walnut Hill Ln #100
StadtIRVING
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75038
Telefon19724869346
Websitehttps://haymakeracquisition.com/
BörsenkürzelBTMD
IPO-datumMar 02, 2021
CEOChristensen (Bret)

Führungskräfte von Biote Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Ms. Debra L. Morris
Ms. Debra L. Morris
Independent Director
Independent Director
--
--
Ms. Dana Jacoby
Ms. Dana Jacoby
Independent Director
Independent Director
--
--
Dr. S. Mark Cone
Dr. S. Mark Cone
Independent Director
Independent Director
--
--
Mr. Robert (Bob) Peterson
Mr. Robert (Bob) Peterson
Chief Financial Officer, Chief Business Officer
Chief Financial Officer, Chief Business Officer
--
--
Mr. Richard R. (Rich) Barrera
Mr. Richard R. (Rich) Barrera
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Andrew R. (Andy) Heyer
Mr. Andrew R. (Andy) Heyer
Independent Director
Independent Director
2.48M
--
Ms. Mary Elizabeth Conlon
Ms. Mary Elizabeth Conlon
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
144.50K
--
Mr. Marc D. Beer
Mr. Marc D. Beer
Executive Chairman of the Board
Executive Chairman of the Board
107.79K
-250.48%
Mr. Bret Christensen
Mr. Bret Christensen
Chief Executive Officer, Principal Executive Officer, Director
Chief Executive Officer, Principal Executive Officer, Director
37.59K
--
Ms. Debra L. Morris
Ms. Debra L. Morris
Independent Director
Independent Director
--
--
Ms. Dana Jacoby
Ms. Dana Jacoby
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Biote Corp?

Die fünf größten Anteilseigner von Biote Corp sind: Mr. Andrew R. (Andy) Heyer

Wie viele Institutionen halten Anteile an Biote Corp (BTMD)?

Mit Stand vom 2026Q1 halten 214 Institutionen Anteile an Biote Corp, mit einem Gesamtmarktwert von etwa 20.55M, was 64.13% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -2349533.00 gestiegen.

Was ist die größte Einnahmequelle von Biote Corp?

Am 2026Q1 erzielte das Geschäft mit Pellet Procedures für Biote Corp den höchsten Umsatz in Höhe von 137.04M, was 71.29% des Gesamtumsatzes entspricht.